Does Humana Cover Vyvanse?
The verdict
Covered on most plans
Humana covers Vyvanse primarily under Medicare Part D — generic lisdexamfetamine is preferred at a low tier, while brand Vyvanse may require prior authorization as formularies shift. A Schedule II 70 mg/day quantity limit applies. For older adults on Part D, prescribers commonly document cardiovascular safety as part of the stimulant PA process. Medicare beneficiaries cannot use manufacturer coupons or savings cards, making the generic the most affordable option. Humana has limited commercial and ACA presence; Medicare Part D is its core book for this drug.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Humana using your member ID.
Medicare vs. commercial coverage
Whether Humana covers Vyvanse depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D (Humana's core LOB): generic lisdexamfetamine is covered and preferred at a low tier; brand Vyvanse may require prior authorization as generic supply stabilizes. A Schedule II 70 mg/day quantity limit applies. For older adults, prescribers typically document cardiovascular safety as part of the stimulant PA — a standard Part D consideration for adult ADHD. Medicare beneficiaries cannot use manufacturer savings cards; the generic is the low-cost path. Verify current tier on the Humana Part D drug list, which is updated annually.
Commercial / Employer
Group & marketplace plans
Humana's commercial/employer book is limited. Where commercial coverage exists, generic lisdexamfetamine is preferred at a low tier with a 70 mg/day QL. ACA/Individual: minimal Humana ACA presence — not the primary LOB. Medicaid (where Humana operates Medicaid managed care): generic covered per state PDL with PA and QL. During 2024, some Humana plans temporarily added brand Vyvanse back due to generic shortage; those add-backs are being reversed as supply improves. Shortage-documented PA or pharmacist override can support brand dispensing when generic is unavailable.
The 5 boxes you must tick to get approved
Commercial plans that will consider Vyvanse require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Vyvanse actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Brand Vyvanse: approx. $400–$558/month (Takeda list price, estimate). Generic lisdexamfetamine: approx. $200–$360/month cash, as low as approx. $60–$70 with a coupon. Note: Medicare Part D beneficiaries cannot use manufacturer savings cards.
List price with no coverage — before any manufacturer savings card.
With coverage
Generic lisdexamfetamine at preferred Part D tier: cost-share depends on Part D phase (deductible, initial coverage, catastrophic) and specific Humana plan. Verify on the Humana Part D drug list. Medicaid: nominal ($0–$4 typical). Brand Vyvanse: non-preferred tier, higher cost-share.
Typical monthly copay once prior authorization is approved.
All cost figures are estimates. Part D cost-share varies by plan, phase, and annual design. Medicare Part D has an annual out-of-pocket cap ($2,100 in 2026 per IRA). Verify on the Humana Part D drug list or by calling Humana member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search the Humana Part D drug list
Go to humana.com and use the Medicare drug coverage lookup with your specific Humana Part D or MA-PD plan ID. Search 'lisdexamfetamine' (generic) and 'Vyvanse' (brand) to see the current tier, quantity limit, and any PA requirements for 2026.
- 2
Call Humana member services
Call the number on the back of your Humana card and ask: (1) Is generic lisdexamfetamine covered on my Part D plan, and at what tier? (2) Does brand Vyvanse require prior authorization? (3) What is the quantity limit? (4) What cardiovascular documentation does my prescriber need to include in the PA?
- 3
Have your prescriber submit the prior authorization
Your prescriber submits documentation of the ADHD (or binge-eating disorder) diagnosis, dose within the 70 mg/day QL, and cardiovascular safety documentation for older adults. For brand Vyvanse, include documentation of generic unavailability if applicable. Humana's Part D PA routing goes through the plan's prior authorization portal — confirm the process with your prescriber.
Options if Humana won't cover Vyvanse
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic lisdexamfetamine
The preferred formulary option on Humana Part D. Same active ingredient as brand Vyvanse; FDA-approved August 2023. Cash approx. $200–$360/month. Medicare Part D beneficiaries cannot use manufacturer coupons — generic at covered tier is the most affordable path. Verify pharmacy stock, as intermittent shortage continues.
Generic amphetamine/dextroamphetamine (Adderall generic)
Generally covered at a low tier on Humana Part D. Different chemical entity from lisdexamfetamine; not FDA-approved for binge-eating disorder. Cash approx. $17–$55/30 days. Prescriber must assess clinical appropriateness for older adults, including cardiovascular considerations.
Non-stimulant ADHD medications (e.g., generic atomoxetine)
For older adults where stimulant cardiovascular risk is a concern, prescribers may consider non-stimulant options like generic atomoxetine (Strattera generic). Typically covered on Humana formularies; verify tier and QL on plan drug list.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes — Humana's Medicare Part D plans cover lisdexamfetamine (generic Vyvanse preferred, brand may need PA) with a 70 mg/day Schedule II quantity limit. Generic lisdexamfetamine (FDA-approved August 2023) is the preferred, lower-cost option. Brand Vyvanse may require prior authorization as formularies transition away from shortage-era add-backs. Verify the current tier and PA requirement on your specific Humana Part D drug list.
No — Medicare Part D beneficiaries are prohibited by federal law from using manufacturer savings cards or coupons (like the Takeda Vyvanse savings card) to lower their cost-share. This rule applies to all Part D plans, including Humana. Generic lisdexamfetamine at the preferred Part D tier is the most affordable covered option for Humana Medicare members. Verify the generic's current tier on your Humana drug list.
Stimulants like lisdexamfetamine increase heart rate and blood pressure, and for older adults on Medicare, prescribers typically document cardiovascular safety as part of the prior authorization. This is standard Part D practice for adult ADHD — not a denial trigger, but a documentation requirement. Your prescriber notes that the benefit of treating ADHD outweighs stimulant cardiovascular risk for your specific situation. Include this documentation proactively to avoid PA delays.
Humana Part D plans apply a Schedule II quantity limit of 70 mg per day for lisdexamfetamine, consistent with FEP-standard criteria (CVS Caremark Policy 5.60.024, eff. April 1, 2026). No automatic refills are permitted; each fill requires a new Schedule II prescription. Verify the exact QL for your specific Humana Part D plan, as plan-level rules may vary.
Humana Part D and commercial plans generally cover lisdexamfetamine for adult binge-eating disorder, consistent with FDA labeling. Prior authorization requires documentation of the BED diagnosis. Coverage on Humana Medicaid managed care plans depends on the state PDL. Verify the BED indication on your specific Humana plan's PA criteria or call member services.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Humana before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.